While gray hair may look “distinguished,” of all the changes associated with aging, one of the most common and devastating is the decline in cognitive function. People fear the loss of independence and control of their life as a result of losing their mental capacity more than they fear losing their physical abilities.
Cases of dementia are starting to skyrocket, and the one disease that is more terrifying and worse than all others (including cancer) is Alzheimer’s. Alzheimer’s is one of the fastest-growing diseases in America and is currently the sixth-leading cause of death. Alzheimer’s used to only be seen in people in their 70’s or 80’s, but is now being seen in 50- and 60-year-old’s, and sometimes even as early as the 30’s and 40’s. And while memory-destroying diseases such as Alzheimer’s are more common with age, they are not an inevitable part of aging. Healthy people do not develop Alzheimer’s disease no matter how old they are!
By the year 2050, it is predicted that as many as two billion people worldwide could be at risk for Alzheimer’s. This is an unprecedented health-care crisis that could cost $1 trillion a year in the US alone. The scope of the looming medical-care disaster is beyond comparison. If this disease is not contained, it may bankrupt the US healthcare system!
Besides the tragic physical toll of Alzheimer’s, the emotional impact on the sufferers and their families can be agonizing. In the latter stages of the disease, many cannot feed or bathe themselves, and they frequently fall and get injured. Some become agitated and combative. Many become incontinent of urine and feces. And most cannot even recognize the people dearest to them, or articulate coherent thoughts and sentences. They lose all sense of self, and they become the equivalent of mental vegetables as their minds turn to mush.
The changes described above lead to a degrading loss of independence and tragic end to a life of the sufferer, and an enormous burden on family caregivers who will experience a high rate of depression, heart attacks, and stroke as a result of the stress. On top of that, the cost to care for someone with Alzheimer’s in a nursing home can exceed $90,000 per year. That’s five times the cost of living independently!
Degenerative changes in the brain leading to Alzheimer’s can begin decades before symptoms appear—sometimes starting as early as age 20! If you have symptoms of forgetfulness, a decreased ability to maintain focus, and decreased problem-solving capacity, you may already be in the early stages of Mild Cognitive Impairment (MCI). Left untreated, MCI can fast-track into full-blown Alzheimer’s disease. Time is not on your side. The outcome of your life may depend on the decisions you make now. If you choose to ignore protecting your brain, you risk losing your memory, your independence, and most importantly, your (and your family’s) quality of life.
Alzheimer’s LINX™ is a breakthrough blood test panel designed to identify key risk factors linked to the development of Alzheimer’s disease (AD) by the latest medical research. It detects immune reactivity to specific environmental antigens and tissues that can contribute to the development of AD and other neurodegenerative conditions.
Alzheimer’s LINX™ is the result of years of intense research and development, led by Dr. Aristo Vojdani, a pioneering immunologist and recognized by many as the Father of Functional Immunology. It is a strategically planned panel of biomarkers that reveals clinical perspectives of brain-related immune reactivity that have never been seen before. Features of this breakthrough test panel include:
- Seven categories of key contributing factors to cognitive decline or other neurodegenerative conditions
- Nearly 40 biomarkers, many of them now offered for the first time
- New blood-brain barrier antibody biomarkers
- New biomarker to test immune reactivity to amyloid-beta
- The eight most cross-reactive foods (out of 208 studied) newly discovered to have a potential association with AD
- New protein biomarkers that reveal immune reactivity and cross-reactivity to key brain cells and neurons at the heart of AD
- New oral bacterial biomarker showed to be associated with AD
- Biomarkers for a collection of chemicals and metals discovered to have associations to AD
- The most reliable laboratory technology on the market performed on the gold standard ELISA platform
Here are the seven key groups and their contributing factors:
Brain Proteins:
Evaluation of brain protein reactivity, including antibodies against tau protein, amyloid-beta, rebaptin-5, presenilin, and alpha-synucleins
Growth Factors:
Measurement of immune reactivity to neuronal regeneration factors, including antibodies against beta nerve growth factor, brain-derived neurotrophic factor, neurotrophins, and somatotropin.
Enteric Nerve, Enzymes, and Neurological Peptides:
Assessment of immune reactivity between the intestine and the brain, including antibodies against the enteric nerve, vasoactive intestinal polypeptide, and transglutaminases.
Pathogens:
Evaluation of immune reactivity to pathogens known to interact with amyloid-beta, including antibodies against oral pathogens, Enterococcus faecalis, herpes type 1, and cytolethal distending toxins produced by Escherichia coli and Campylobacter jujuni.
Chemicals:
Biomarkers found to have associations with AD for a collection of chemicals and heavy metals, including antibodies against tissue contaminated with aluminum, ethyl and methyl mercury, dinitrophenyl, and phthalates.
Foods Cross-Reactive to Amyloid Beta:
Eight out of 208 common foods have recently been identified as having a potential association with AD, including antibodies against egg yolk (raw and cooked), lentil and pea lectins, canned tuna, hazelnut and cashew vicilin, scallops, and squid.
Blood-Brain Barrier and Neurofilaments:
Breaches in the integrity of the blood-brain barrier, including antibodies against blood-brain barrier protein, claudin-5, aquaporins, and neurofilament proteins.
NOTE FROM DR. THOMAS: People can and do recover from cancer. However, people cannot and do not recover from Alzheimer’s disease. Alzheimer’s is the one disease that MUST be prevented. Please do not wait until it’s too late. To learn if you are at risk, I urge you to take the Alzheimer’s LINX™ blood test.
Alzheimer’s LINX™ detects key antibodies up to 20 years BEFORE symptoms of memory loss actually appear. Furthermore, it provides a detailed road map of WHAT is putting you at risk for Alzheimer’s disease. Armed with this knowledge, an experienced doctor trained in functional medicine can provide safe and effective treatments to address the specific issues. The cost of Alzheimer’s LINX™ is $1500 and is worth every penny!
